UNSPSC 51142521: Ciladopa

This classification denotes a dopamine agonist with the molecular formula C21H26N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D09L486R3J, chemically known as 2,4,6-cycloheptatrien-1-one, 2-(4-(2-(3,4-dimethoxyphenyl)-2-hydroxyethyl)-1-piperazinyl)-, (s)- but generally known as ciladopa, which bears US NIH Compound Identifier 133371. European Medicines Agency schedules Ciladopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06262MIG.

UNSPSC 51142521 Ciladopa is a Commodity code that represents pharmaceutical products, though the recent state and local activity under this code does not align with the nominal scope — the single solicitation on record involves procurement of naloxone and drug deactivation systems for community health support, not ciladopa specifically. Seminole County, Florida posted an IFB seeking to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding. The work involves quarterly deliveries to a county health facility, with vendors responsible for all shipping and delivery costs. Bidders must submit electronically, provide unit costs for each line item, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The initial contract term runs two years with an option for one-year renewal, and includes a three-month probationary period during which the county may terminate with or without cause. The procurement may be funded through FEMA, introducing additional federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act.

The code shows minimal recent state and local activity relevant to its nominal pharmaceutical scope. The single posted opportunity is from Seminole County, Florida (IFB 60459723LAS, due July 26, 2023, with questions due July 21, 2023). No other jurisdictions or repeat buyers appear in the recent record, and the geographic spread cannot be characterized beyond this single Florida procurement. The mismatch between the code's name and the actual solicitation content — naloxone and drug deactivation systems rather than ciladopa — suggests either a tagging error or that the code is not actively used for state and local pharmaceutical procurement at present.